Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, American College of Cardiology

Research output: Contribution to journalArticle

73 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)e273-e280
JournalCirculation
Volume132
Issue number22
DOIs
StatePublished - Dec 1 2015

Fingerprint

Cardiovascular Abnormalities
Arrhythmogenic Right Ventricular Dysplasia
Hypertrophic Cardiomyopathy
Myocarditis
Advisory Committees
Sudden Death
Cardiology
Cardiomyopathies
Athletes

Keywords

  • AHA Scientific Statements
  • arrhythmogenic right ventricular cardiomyopathy
  • athletes
  • cardiomyopathy
  • cardiovascular abnormalities
  • cardiovascular magnetic resonance
  • hypertrophic cardiomyopathy
  • myocarditis
  • sudden death

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, & American College of Cardiology (2015). Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation, 132(22), e273-e280. https://doi.org/10.1161/CIR.0000000000000239

Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities : Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. / on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Functional Genomics and Translational Biology; American College of Cardiology.

In: Circulation, Vol. 132, No. 22, 01.12.2015, p. e273-e280.

Research output: Contribution to journalArticle

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology & American College of Cardiology 2015, 'Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology', Circulation, vol. 132, no. 22, pp. e273-e280. https://doi.org/10.1161/CIR.0000000000000239
on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 1;132(22):e273-e280. https://doi.org/10.1161/CIR.0000000000000239
on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology ; Council on Cardiovascular Disease in the Young ; Council on Cardiovascular and Stroke Nursing ; Council on Functional Genomics and Translational Biology ; American College of Cardiology. / Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities : Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. In: Circulation. 2015 ; Vol. 132, No. 22. pp. e273-e280.
@article{b01b55e12b2d4ac8879a5009795e2e4d,
title = "Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology",
keywords = "AHA Scientific Statements, arrhythmogenic right ventricular cardiomyopathy, athletes, cardiomyopathy, cardiovascular abnormalities, cardiovascular magnetic resonance, hypertrophic cardiomyopathy, myocarditis, sudden death",
author = "{on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology} and {Council on Cardiovascular Disease in the Young} and {Council on Cardiovascular and Stroke Nursing} and {Council on Functional Genomics and Translational Biology} and {American College of Cardiology} and Maron, {Barry J.} and Udelson, {James E.} and Bonow, {Robert O.} and Nishimura, {Rick A.} and Ackerman, {Michael John} and Estes, {N. A Mark} and Cooper, {Leslie T Jr.} and Link, {Mark S.} and Maron, {Martin S.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1161/CIR.0000000000000239",
language = "English (US)",
volume = "132",
pages = "e273--e280",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "22",

}

TY - JOUR

T1 - Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities

T2 - Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

AU - on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology

AU - Council on Cardiovascular Disease in the Young

AU - Council on Cardiovascular and Stroke Nursing

AU - Council on Functional Genomics and Translational Biology

AU - American College of Cardiology

AU - Maron, Barry J.

AU - Udelson, James E.

AU - Bonow, Robert O.

AU - Nishimura, Rick A.

AU - Ackerman, Michael John

AU - Estes, N. A Mark

AU - Cooper, Leslie T Jr.

AU - Link, Mark S.

AU - Maron, Martin S.

PY - 2015/12/1

Y1 - 2015/12/1

KW - AHA Scientific Statements

KW - arrhythmogenic right ventricular cardiomyopathy

KW - athletes

KW - cardiomyopathy

KW - cardiovascular abnormalities

KW - cardiovascular magnetic resonance

KW - hypertrophic cardiomyopathy

KW - myocarditis

KW - sudden death

UR - http://www.scopus.com/inward/record.url?scp=84949324348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949324348&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000239

DO - 10.1161/CIR.0000000000000239

M3 - Article

C2 - 26621644

AN - SCOPUS:84949324348

VL - 132

SP - e273-e280

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 22

ER -